Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
CD1E Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1e, membrane-associated Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CD1E Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD1e, membrane-associated Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD1E protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CD99 Biologics Sequence Review Report 2026: CD99 antigen Similarity and Patent-Risk Signals
8 min read
CD99 Biologics Sequence Review Report 2026: CD99 antigen Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD99 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CD8B Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD8 beta chain Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CD8B Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD8 beta chain Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD8B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
NR5A2 Biologics Sequence Review Report 2026: Nuclear receptor subfamily 5 group A member 2 Similarity and Patent-Risk Signals
8 min read
NR5A2 Biologics Sequence Review Report 2026: Nuclear receptor subfamily 5 group A member 2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of NR5A2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GFRA2 Biologics Sequence Review Report 2026: GDNF family receptor alpha-2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GFRA2 Biologics Sequence Review Report 2026: GDNF family receptor alpha-2 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GFRA2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
BMAL1 Biologics Sequence Review Report 2026: Basic helix-loop-helix ARNT-like protein 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
BMAL1 Biologics Sequence Review Report 2026: Basic helix-loop-helix ARNT-like protein 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of BMAL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PGRMC1 Biologics Sequence Review Report 2026: Membrane-associated progesterone receptor component 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PGRMC1 Biologics Sequence Review Report 2026: Membrane-associated progesterone receptor component 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of PGRMC1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GET1 Biologics Sequence Review Report 2026: Guided entry of tail-anchored proteins factor 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GET1 Biologics Sequence Review Report 2026: Guided entry of tail-anchored proteins factor 1 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GET1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
F2RL2 Biologics Sequence Review Report 2026: Proteinase-activated receptor 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
F2RL2 Biologics Sequence Review Report 2026: Proteinase-activated receptor 3 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of F2RL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
GRM8 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 8 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
GRM8 Biologics Sequence Review Report 2026: Metabotropic glutamate receptor 8 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of GRM8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
AIP Biologics Sequence Review Report 2026: AH receptor-interacting protein Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
AIP Biologics Sequence Review Report 2026: AH receptor-interacting protein Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of AIP protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
CD5 Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
CD5 Biologics Sequence Review Report 2026: T-cell surface glycoprotein CD5 Similarity and Patent-Risk Signals
4 August 2026
A Biology Modality MCP review of CD5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →